about
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...
Read More
85.03
1.14
(1.36%)
30,613.3
XNAS Volume
XNAS 06 Aug, 2026 12:04 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Inhibrx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..